MARKET PULSE-Cytori, Endo Health, Leapfrog, AOL, Cognizant

Tue Nov 5, 2013 7:39am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter

Nov 5 (Reuters) - U.S. stock index futures retreated on Tuesday. S&P 500 futures fell 0.29 percent, Dow Jones industrial average futures fell 0.34 percent and Nasdaq 100 futures fell 0.34 percent.

** CYTORI THERAPEUTICS INC, Monday close $2.09, up 51 pct premarket

The medical device maker said on Monday it would receive up to $531 million from Chinese company Lorem Vascular as license fee for its stem cell therapy that removes fat cells from a patient's body. These cells, which are then injected into the affected area, increase blood profusion and heal the wound. Lorem will market the therapy in Asia-Pacific.

** ENDO HEALTH SOLUTIONS INC, Monday close $43.64, up 14.5 pct premarket

The specialty pharmaceutical company said it would acquire Canadian peer Paladin Labs Inc for about $1.6 billion to expand its presence in Canada and emerging markets.